NM_000426.4:c.3718C>T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000426.4(LAMA2):c.3718C>T(p.Gln1240*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000426.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMA2 | ENST00000421865.3 | c.3718C>T | p.Gln1240* | stop_gained | Exon 25 of 65 | 5 | NM_000426.4 | ENSP00000400365.2 | ||
LAMA2 | ENST00000618192.5 | c.3982C>T | p.Gln1328* | stop_gained | Exon 26 of 66 | 5 | ENSP00000480802.2 | |||
LAMA2 | ENST00000617695.5 | c.3718C>T | p.Gln1240* | stop_gained | Exon 25 of 64 | 5 | ENSP00000481744.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Merosin deficient congenital muscular dystrophy Pathogenic:2
- -
- -
LAMA2-related muscular dystrophy Pathogenic:1
ClinVar contains an entry for this variant (Variation ID: 14290). This sequence change creates a premature translational stop signal (p.Gln1240*) in the LAMA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA2 are known to be pathogenic (PMID: 18700894, 32904964). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal recessive congenital muscular dystrophy (PMID: 7550355). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
- -
Qualitative or quantitative defects of merosin Pathogenic:1
The homozygous p.Gln1240Ter variant in LAMA2 was identified in our study in one individual with muscular dystrophy. The p.Gln1240Ter variant in LAMA2 has been previously reported in two unrelated individuals with LAMA2-related muscular dystrophy (PMID: 34559299, PMID: 7550355). Of these previously reported affected individuals (PMID: 34559299, PMID: 7550355), one was a homozygote and the individual identified by our study was a homozygote, which increases the likelihood that p.Gln1240Ter variant is pathogenic. This variant has also been reported in ClinVar (Variation ID: 14290) and has been interpreted as pathogenic by OMIM, Invitae, and Eurofins NTD LLC and as likely pathogenic by Counsyl. This variant was absent from large population studies. This nonsense variant leads to a premature termination codon at position 1240, which is predicted to lead to a truncated or absent protein. Loss of function of the LAMA2 gene is an established disease mechanism in autosomal recessive LAMA2-related muscular dystrophy. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive LAMA2-related muscular dystrophy. ACMG/AMP Criteria applied: PVS1, PM2_Supporting, PM3 (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at